405
Views
6
CrossRef citations to date
0
Altmetric
Studies in Humans

Effects of a soybean nutrition bar on the postprandial blood glucose and lipid levels in patients with diabetes mellitus

, , , , &
Pages 921-929 | Published online: 20 Jun 2012

References

  • Abrahamsson H. 1995. Gastrointestinal motility disorders in patients with diabetes mellitus. J Intern Med. 237:403–409.
  • Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 333:276–282.
  • Augustin LS, Franceschi S, Jenkins DJ. 2002. Glycemic index in chronic disease: a review. Eur J Clin Nutr. 56:1049–1071.
  • Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, . 2007. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 85:735–741.
  • Badger TM, Ronis MJ, Hakkak R. 2002. The health consequences of early soy consumption. J Nutr. 132:559S–565S.
  • Badger TM, Ronis MJ, Wolff G, Stanley S, Ferguson M, Shankar K, . 2008. Soy protein isolate reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype. Exp Biol Med (Maywood). 233:1242–1254.
  • Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, . 2008. Glycemic index, glycemic load, and chronic disease risk – a meta-analysis of observational studies. Am J Clin Nutr. 87:627–637.
  • Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, . 2001. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 24:1936–1940.
  • Brand-Miller JC, Holt SH, Pawlak DB, McMillan J. 2002. Glycemic index and obesity. Am J Clin Nutr. 76:281S–5S.
  • Brand-Miller J, Petocz P, Colagiuri S. 2003. Low glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care. 26:2261–2267.
  • Cederroth CR, Vinciguerra M, Gjinovci A, Kühne F, Klein M, Cederroth M, . 2008. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes. 57:1176–1185.
  • Coates PA, Ollerton RL, Luzio SD, Ismail I, Owens DR. 1994. A glimpse of the natural history of established type 2 diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis. Diabetes Res Clin Pract. 31:177–187.
  • Erdman JWJr. 2000. AHA science advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation. 102:2555–2559.
  • Feinle C, O'Donovan D, Horowitz M. 2002. Carbohydrate and satiety. Nutr Rev. 60:155–169.
  • Forman JP, Stampfer MJ, Curhan GC. 2009. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 302:401–411.
  • Foster-Powell K, Holt SH, Brand-Miller JC. 2002. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 76:5–56.
  • Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB, . 2008. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 168:713–720.
  • Harano Y, Miyawaki T, Nabiki J, Shibachi M, Adachi T, Ikeda M, . 2006. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J. 53:173–178.
  • Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B. 2001. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 24:228–233.
  • Holt SH, Miller JC, Petocz P. 1997. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr. 66:1264–1276.
  • Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, . 2006. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 101:246–253.
  • International Diabetes Federation. 2007. Guidrine for management of postmeal glucose, Available at: http://www.idf.org/webdata/docs/Guideline_PMG_final.pdf. 1–12 Last accessed 20 October 2011.
  • Iovine C, Vaccaro O, Gentile A, Romano G, Pisanti F, Riccardi G, . 2004. Post-prandial triglyceride profile in a population-based sample of type 2 diabetic patients. Diabetologia. 47:19–22.
  • Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, . 1981. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 34:362–366.
  • Jenkins DJ, Kendall CW, Augustin LSA. 2002. Glycemic index: overview of implications in health and disease. Am J Clin Nutr. 76:266S–273S.
  • Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, . 2008. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA. 300:2742–2753.
  • Juhan-Vague I, Thompson SG, Jespersen J. 1993. Involvement of hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. Arterioscler Thromb. 13:1865–1873.
  • Kavanagh K, Jones KL, Zhang L, Flynn DM, Shadoan MK, Wagner JD. 2008. High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates. Nutr Res. 28:368–376.
  • Levitt MD, Donaldson RM. 1970. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med. 75:937–945.
  • Levitan EB, Wolk A, Mittleman MA. 2009. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med. 169:851–857.
  • Liese AD, Nichols M, Sun X, D'Agostino RBJr, Haffner SM. 2009. Adherence to the DASH diet is inversely associated with incidence of type 2 diabetes: insulin resistance atherosclerosis study. Diabetes Care. 32:1434–1436.
  • Ludwig DS. 2002. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 87:2414–2423.
  • Marsh K, Barclay A, Colagiuri S, Brand-Miller J. 2011. Glycemic index and glycemic load of carbohydrates in the diabetes diet. Curr Diab Rep. 11:120–127.
  • Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC. 2010. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr. 92:83–92.
  • Messina M, Erdman JJr, Setchell KD. 2004. Introduction to and perspectives from the Fifth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. J Nutr. 134:1205S–1206S.
  • Messina M. 1999. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am J Clin Nutr. 70:574–575.
  • Mezei O, Li Y, Mullen E, Ross-Viola JS, Shay NF. 2006. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms. Physiol Genomics. 26:8–14.
  • Mezei O, Banz WJ, Steger RW, . 2003. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr. 133:1238–1243.
  • Montonen J, Knekt P, Järvinen R, Aromaa A, Reunanen A. 2003. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr. 77:622–629.
  • Nagata C, Takatsuka N, Kurisu Y, Shimizu H. 1998. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr. 128:209–213.
  • Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M, . 2010. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr. 140:580–586.
  • Oku T, Nakamura M, Takasugi A, Hashiguchi-Ishiguro M, Tanabe K, Nakamura S. 2009. Effects of cake made from whole soy powder on postprandial blood glucose and insulin levels in human subjects. Int J Food Sci Nutr. 60 Suppl. 4: 224–231.
  • Pastromas S, Terzi AB, Tousoulis D, Koulouris S. 2008. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol. 126:3–12.
  • Rivellese AA, De Natale C, Di Marino L, Patti L, Iovine C, Coppola S, . 2004. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab. 89:2153–2159.
  • Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, . 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344:1343–1350.
  • Tushuizen ME, Diamant M, Heine RJ. 2005. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes. Postgrad Med J. 81:1–6.
  • Villegas R, Gao YT, Yang G, Li HL, Elasy TA, Zheng W, . 2008. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai women's health study. Am J Clin Nutr. 87:162–167.
  • Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. 1997. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 46:698–705.
  • Warren JM, Henry JK, Simonite V. 2003. Low glycemic index breakfasts and reduced food intake in preadolescent children. Pediatrics. 112:414–420.
  • Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 27:1047–1053.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.